Fundamental Analysis of ALTIMMUNE INC(NASDAQ:ALT) stock

Fundamental Rating

ALT gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 588 industry peers in the Biotechnology industry. No worries on liquidiy or solvency for ALT as it has an excellent financial health rating, but there are worries on the profitability. ALT is quite expensive at the moment. It does show a decent growth rate.

Quickly go to:

1. Profitability

1.1 Basic Checks

ALT had negative earnings in the past year.

ALT had a negative operating cash flow in the past year.

ALT had negative earnings in each of the past 5 years.

ALT had a negative operating cash flow in each of the past 5 years.

1.2 Ratios

ALT has a Return On Assets (-41.99%) which is in line with its industry peers.

ALT's Return On Equity of -45.56% is fine compared to the rest of the industry. ALT outperforms 70.60% of its industry peers.

		Industry Rank	Sector Rank
ROA	-41.99%
ROE	-45.56%
ROIC	N/A

ROA(3y)-42.43%

ROA(5y)-37.21%

ROE(3y)-46.68%

ROE(5y)-41.57%

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

ALT does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	N/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5YN/A

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

ALT does not have a ROIC to compare to the WACC, probably because it is not profitable.

ALT has more shares outstanding than it did 1 year ago.

The number of shares outstanding for ALT has been increased compared to 5 years ago.

There is no outstanding debt for ALT. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.

2.2 Solvency

ALT has an Altman-Z score of 10.15. This indicates that ALT is financially healthy and has little risk of bankruptcy at the moment.

Looking at the Altman-Z score, with a value of 10.15, ALT belongs to the top of the industry, outperforming 87.01% of the companies in the same industry.

ALT has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.

		Industry Rank	Sector Rank
Debt/Equity	0
Debt/FCF	N/A
Altman-Z	10.15

ROIC/WACCN/A

WACC9.23%

2.3 Liquidity

A Current Ratio of 17.26 indicates that ALT has no problem at all paying its short term obligations.

ALT's Current ratio of 17.26 is amongst the best of the industry. ALT outperforms 93.16% of its industry peers.

A Quick Ratio of 17.26 indicates that ALT has no problem at all paying its short term obligations.

The Quick ratio of ALT (17.26) is better than 93.16% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	17.26
Quick Ratio	17.26

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

ALT shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 18.64%, which is quite good.

Looking at the last year, ALT shows a very strong growth in Revenue. The Revenue has grown by 710.00%.

ALT shows a very negative growth in Revenue. Measured over the last years, the Revenue has been decreasing by -47.15% yearly.

EPS 1Y (TTM)18.64%

EPS 3YN/A

EPS 5YN/A

EPS growth Q2Q23.26%

Revenue 1Y (TTM)710%

Revenue growth 3Y-62.67%

Revenue growth 5Y-47.15%

Revenue growth Q2Q133.64%

3.2 Future

Based on estimates for the next years, ALT will show a very strong growth in Earnings Per Share. The EPS will grow by 38.69% on average per year.

Based on estimates for the next years, ALT will show a very strong growth in Revenue. The Revenue will grow by 326.68% on average per year.

EPS Next Y29.91%

EPS Next 2Y-11.49%

EPS Next 3Y-17.08%

EPS Next 5Y38.69%

Revenue Next Year12088.1%

Revenue Next 2Y-41.42%

Revenue Next 3Y-25.99%

Revenue Next 5Y326.68%

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

ALT reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.

Also next year ALT is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A

4.2 Price Multiples

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	N/A

4.3 Compensation for Growth

A cheap valuation may be justified as ALT's earnings are expected to decrease with -17.08% in the coming years.

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2Y-11.49%

EPS Next 3Y-17.08%

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

No dividends for ALT!.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

ALTIMMUNE INC

NASDAQ:ALT (4/18/2024, 7:00:00 PM)

After market: 6.86 -0.03 (-0.44%)

6.89

-0.15 (-2.13%)

Chartmill FA Rating

GICS SectorHealth Care

GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences

GICS IndustryBiotechnology

Earnings (Last)

Earnings (Next)

Inst Owners

Inst Owner Change

Ins Owners

Ins Owner Change

Market Cap370.20M

Analysts

Price Target

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Dividend Growth(5Y)

Div Incr Years

Div Non Decr Years

Ex-Date

Surprises & Revisions

EPS beat(2)

Avg EPS beat(2)

Min EPS beat(2)

Max EPS beat(2)

EPS beat(4)

Avg EPS beat(4)

Min EPS beat(4)

Max EPS beat(4)

EPS beat(8)

Avg EPS beat(8)

EPS beat(12)

Avg EPS beat(12)

EPS beat(16)

Avg EPS beat(16)

Revenue beat(2)

Avg Revenue beat(2)

Min Revenue beat(2)

Max Revenue beat(2)

Revenue beat(4)

Avg Revenue beat(4)

Min Revenue beat(4)

Max Revenue beat(4)

Revenue beat(8)

Avg Revenue beat(8)

Revenue beat(12)

Avg Revenue beat(12)

Revenue beat(16)

Avg Revenue beat(16)

PT rev (1m)

PT rev (3m)

EPS NQ rev (1m)

EPS NQ rev (3m)

EPS NY rev (1m)

EPS NY rev (3m)

Revenue NQ rev (1m)

Revenue NQ rev (3m)

Revenue NY rev (1m)

Revenue NY rev (3m)

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA

EPS(TTM)

EPS(NY)

Fwd EY

FCF(TTM)

FCFY

OCF(TTM)

OCFY

SpS

BVpS

TBVpS

PEG (NY)N/A

PEG (5Y)N/A

Profitability

		Industry Rank	Sector Rank
ROA	-41.99%
ROE	-45.56%
ROCE
ROIC
ROICexc
ROICexgc
OM	N/A
PM (TTM)	N/A
GM	N/A
FCFM

ROA(3y)

ROA(5y)

ROE(3y)

ROE(5y)

ROIC(3y)

ROIC(5y)

ROICexc(3y)

ROICexc(5y)

ROICexgc(3y)

ROICexgc(5y)

ROCE(3y)

ROCE(5y)

ROICexcg growth 3Y

ROICexcg growth 5Y

ROICexc growth 3Y

ROICexc growth 5Y

OM growth 3Y

OM growth 5Y

PM growth 3Y

PM growth 5Y

GM growth 3Y

GM growth 5Y

F-Score

Asset Turnover0

Health

		Industry Rank	Sector Rank
Debt/Equity	0
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio	17.26
Quick Ratio	17.26
Altman-Z

F-Score

WACC

ROIC/WACC

Cap/Depr(3y)

Cap/Depr(5y)

Cap/Sales(3y)

Cap/Sales(5y)

Profit Quality(3y)

Profit Quality(5y)

Growth

EPS 1Y (TTM)18.64%

EPS 3YN/A

EPS 5Y

EPS growth Q2Q

EPS Next Y29.91%

EPS Next 2Y

EPS Next 3Y

EPS Next 5Y

Revenue 1Y (TTM)710%

Revenue growth 3Y-62.67%

Revenue growth 5Y

Revenue growth Q2Q

Revenue Next Year

Revenue Next 2Y

Revenue Next 3Y

Revenue Next 5Y

EBIT growth 1Y

EBIT growth 3Y

EBIT growth 5Y

EBIT Next Year

EBIT Next 3Y

EBIT Next 5Y

FCF growth 1Y

FCF growth 3Y

FCF growth 5Y

OCF growth 1Y

OCF growth 3Y

OCF growth 5Y

ALTIMMUNE INC (ALT)

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens